Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.62 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | TSHR | P16473 | 2/20 | 0.62 |
| ▸ | GLA | P06280 | 1/20 | 0.62 |
| ▸ | EIF4E | P06730 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | TOP1 | P11387 | 1/20 | 0.62 |
| ▸ | THPO | P40225 | 1/20 | 0.62 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.62 |
| ▸ | TMEM97 | Q5BJF2 | 2/20 | 0.47 |
| ▸ | HTR2C | P28335 | 1/20 | 0.47 |
| ▸ | HTR2B | P41595 | 1/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | PNP | P00491 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13186245 | 1.00 | LMNA (0.62) | LMNASMN1; SMN2ADORA1ALDH1A1TSHR | |
| SCHEMBL13186258 | 1.00 | LMNA (0.62) | LMNASMN1; SMN2ADORA1ALDH1A1TSHR | |
| SCHEMBL13754496 | 1.00 | LMNA (0.62) | LMNASMN1; SMN2ADORA1ALDH1A1TSHR | |
| SCHEMBL21888891 | 0.83 | LMNA (0.51) | LMNASMN1; SMN2ADORA1ALDH1A1TSHR | |
| SCHEMBL23316241 | 0.81 | LMNA (0.52) | LMNASMN1; SMN2ADORA1ALDH1A1TSHR | |
| SCHEMBL21887941 | 0.80 | LMNA (0.46) | LMNASMN1; SMN2ADORA1ALDH1A1TSHR | |
| SCHEMBL21888132 | 0.79 | LMNA (0.45) | LMNASMN1; SMN2ADORA1ALDH1A1TSHR | |
| SCHEMBL21888080 | 0.77 | LMNA (0.43) | LMNASMN1; SMN2ADORA1ALDH1A1TSHR | |
| SCHEMBL11654052 | 0.77 | LMNA (0.62) | LMNASMN1; SMN2ADORA1ALDH1A1TSHR | |
| SCHEMBL13754497 | 0.77 | LMNA (0.62) | LMNASMN1; SMN2ADORA1ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023014360-A1 | TREATMENT AND DIAGNOSIS OF IMMUNE DISORDERS RELATING TO ABERRANT IMMUNE CELLS | OCTAGON THERAPEUTICS, INC. (US) | 2023-02-09 | — | — | WO | disclosed |
| EP-1240899-A2 | Modulation of Th1/Th2 Cytokine expression by Ribavirin and Ribavirin analogs in actived T-Lymphocytes for treating HCV infections | ICN Pharmaceuticals, Inc. (US) | 2002-09-18 | — | — | EP | disclosed |
| EP-1174141-A2 | Modulation of TH1/TH2 cytokine expression by ribavirin and ribavirin analogs in activated t-lymphocytes | ICN Pharmaceuticals, Inc. (US) | 2002-01-23 | — | — | EP | disclosed |
| EP-0879056-A4 | MODULATION OF TH1/TH2 CYTOKINE EXPRESSION BY RIBAVIRIN-m(3) AND RIBAVIRIN-m(3) ANALOGS IN ACTIVATED T-LYMPHOCYTES | ICN PHARMACEUTICALS (US) | 1999-01-13 | — | — | EP | disclosed |
| EP-0879056-A1 | MODULATION OF TH1/TH2 CYTOKINE EXPRESSION BY RIBAVIRIN$m(3) AND RIBAVIRIN$m(3) ANALOGS IN ACTIVATED T-LYMPHOCYTES | ICN Pharmaceuticals, Inc. (US) | 1998-11-25 | — | — | EP | disclosed |
| WO-1997026883-A1 | MODULATION OF TH1/TH2 CYTOKINE EXPRESSION BY RIBAVIRIN® AND RIBAVIRIN® ANALOGS IN ACTIVATED T-LYMPHOCYTES | ICN PHARMACEUTICALS, INC. (US) | 1997-07-31 | — | — | WO | disclosed |